Target Discovery and Validation Reviews and Protocols

Overview of Immune System 315
42. Hogg, N. and Landis, R. C. (1993) Adhesion molecules in cell interactions. Curr.
Opin. Immunol. 5, 383–390.
43. Chen, L. (2004) Co-inhibitory molecules of the B7-CD28 family in the control of
T-cell immunity. Nat. Rev. Immunol. 4, 336–347.
44. Clark, E. A. and Ledbetter, J. A. (1994) How B and T cells talk to each other.
Nature 367, 425–428.
45. Stevens, T. L., Bossie, A., Sanders, V. M., et al. (1988) Regulation of antibody
isotype secretion by subsets of antigen-specific helper T cells. Nature 334,
255–258.
46. Swain, S. L., Bradley, L. M., Croft, M., et al. (1991) Helper T-cell subsets: phenotype,
function and the role of lymphokines in regulating their development.
Immunol. Rev. 123, 115–144.
47. Bonifacio, E., Scirpoli, M., Kredel, K., Föchtenbusch, M., and Ziegler, A.-G.
(1999) Early autoantibody responses in prediabetes are IgG1 dominated and suggest
antigen-specific regulation. J. Immunol. 163, 525–532.
48. Weiner, H. L. (2001) Induction and mechanism of action of transforming growth
factor-beta-secreting Th3 regulatory cells. Immunol. Rev. 182, 207–214.
49. Shevach, E. M. (2001) Certified professionals: CD4(+)CD25(+) suppressor
T cells. J. Exp. Med. 193, F41–F46.
50. Pardoll, D. (2003) Does the immune system see tumors as foreign or self? Annu.
Rev. Immunol. 21, 807–839.
51. Boon, T. and Kellermann, O. (1977) Rejection by syngeneic mice of cell variants
obtained by mutagenesis of a malignant teratocarcinoma cell line. Proc. Natl.
Acad. Sci. USA 74, 272–275.
52. Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., and Schreiber, R. D. (2002) Cancer
immunoediting: from immunosurveillance to tumor escape. Nat. Immunol. 3,
991–998.
53. Rosenberg, S. A., Yang, J. C., and Restifo, N. P. (2004) Cancer immunotherapy:
moving beyond current vaccines. Nat. Med. 10, 909–915.
54. Pfreundschuh, M., Shiku, H., Takahashi, T., et al. (1978) Serological analysis of
cell surface antigens of malignant human brain tumors. Proc. Natl. Acad. Sci.
USA 75, 5122–5126.
55. Van Bleek, G. M. and Natheson, S. G. (1990) Isolation of an endogenously
processed immunodominant viral peptide from the class I H-2Kb molecule.
Nature 348, 213–216.
56. Falk, K., Rotzschke, O., Stevanovic, S., Jung, G., and Rammensee, H. G. (1991)
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC
molecules. Nature 351, 290–296.
57. van der Bruggen, P., Traversari, C., Chomez, P., et al. (1991) A gene encoding an
antigen recognized by cytolytic T lymphocytes on a human melanoma. Science
254, 1643–1647.
58. Sahin, U., Tureci, O., Chen, Y. T., et al. (1998) Expression of multiple
cancer/testis (CT) antigens in breast cancer and melanoma: basis for polyvalent
CT vaccine strategies. Int. J. Cancer 78, 387–389.